公开(公告)号：US20240173314A1

公开(公告)日：2024-05-30

申请号：US18551214

申请日：2022-03-17

申请人： ZYDUS LIFESCIENCES LIMITED

发明人： Mukul JAIN ,  Amit JOHARAPURKAR ,  Vishal PATEL

IPC分类号： A61K31/4704 ,  A61K45/06 ,  A61P7/06

CPC分类号： A61K31/4704 ,  A61K45/06 ,  A61P7/06

摘要： Present invention relates to development of compound of formula (Ia) for treatment of sickle cell anaemia. Invention also relates to the pharmaceutical composition comprising compound of formula (Ia) or its pharmaceutically acceptable salts for treatment of sickle cell anaemia.

公开(公告)号：US20230241044A1

公开(公告)日：2023-08-03

申请号：US17928557

申请日：2021-05-28

申请人： ZYDUS LIFESCIENCES LIMITED

发明人： Mukul JAIN ,  Amit JOHARAPURKAR ,  Vishal PATEL

IPC分类号： A61K31/4418 ,  A61K31/5377 ,  A61K45/06 ,  A61K31/515 ,  A61K31/4704 ,  A61P17/06

CPC分类号： A61K31/4418 ,  A61K31/515 ,  A61K31/4704 ,  A61K31/5377 ,  A61K45/06 ,  A61P17/06

摘要： Present invention relates to development of prolyl hydroxylase inhibitor for treatment of Psoriasis and skin inflammatory diseases. Specifically, invention relates to development of compound of formula (Ia) for treatment of Psoriasis and skin inflammatory diseases. Invention also relates to pharmaceutical composition comprising compound of formula (Ia) for treatment of Psoriasis and skin inflammatory diseases.